|
|
Clinical observation of different doses of astragalus compound on patients with spinal cord injury with Qi deficiency and blood stasis |
ZHENG Xiuxia, HUANG Baoying, LAI Zijian, ZHU Zuwei, ZENG Wei, LU Xuhui, CHEN Yuxin. |
Department of Traditional Chinese Medicine, the Affiliated Ningde Hosipital of Fujian Medical University, Ningde, 352100 |
|
Cite this article: |
ZHENG Xiuxia,HUANG Baoying,LAI Zijian, et al. Clinical observation of different doses of astragalus compound on patients with spinal cord injury with Qi deficiency and blood stasis[J]. JOURNAL OF WEZHOU MEDICAL UNIVERSITY, 2017, 47(11): 828-831,835.
|
|
Abstract Objective: To observe the clinical effect of different doses of astragalus membranaceus on the patients with spinal cord injury due to Qi deficiency and blood stasis in Buyang Huanwu Decoction, and to provide the basis for clinical medication. Methods: Ninty spinal cord injury with Qi deficiency and blood stasis syndrome cases from July 2015 to December 2016 in orthopedics department of the Affiliated Ningde Hospital of Fujian Medical University, according to the order of the patients entered the trial, and to the random number table, randomly divided into 3 groups. Each group based on basic treatment, in a week after injury for traditional Chinese medicine (TCM) treatment, last one month, each group use basic prescription Buyang Huanwu Decoction. Group A with astragalus 30 grams, group B with 60 grams and group C with 120 grams, evaluated TCM syndrome score, the degree of spinal cord injury, activities of daily living (ADL) ability before and after traditional Chinese medicine treatment, judging TCM main symptoms and treatment efficacy after traditional Chinese medicine. Results: Compared with the main symptoms of Qi deficiency syndrome, group C was better than that of group A and B, the difference was statistically significant (P<0.05), group B was better than group A, the difference was statistically significant (P<0.05). Compared with the main symptoms of blood stasis syndrome, group C was better than that of group A and B, the difference was statistically significant (P<0.05), group B was better than group A, the difference was statistically significant (P<0.05). There was no significant difference between group A and B in the degree of SCI classification; the difference between group C and B was statistically significant, and also group C and A (P<0.05). Compared with ADL, there was no significant difference between group A and B, but the difference between group C and B was statistically significant, and also group C and A (P<0.05). Conclusion: Astragalus membranaceus 120 grams group is better than 60 grams group and 30 grams group in the treatment of SCI patients with Qi deficiency and blood stasis syndrome in different doses of Buyang Huanwu Decoction, which has a certain degree of dependence on measurement.
|
Received: 07 April 2017
|
|
|
|
|
[1] 胥少汀, 郭世绂. 脊髓损伤基础与临床[M]. 北京: 人民卫生出版社, 2002: 193-194.
[2] 刘汝专. 活血化瘀中药治疗脊髓损伤的研究概况[J]. 云南中医中药杂志, 2007, 28(4): 43-45.
[3] 李国辉. 补阳还五汤对谷氨酸体外诱导脊髓神经元损伤大鼠的保护作用研究[J]. 中药研究, 2010, 21(35): 3265-3266.
[4] 虞琴, 陈洪, 王敦林. 补阳还五汤对大鼠脊髓损伤后P物质表达的影响[J]. 时珍国医国药, 2009, 20(6): 1500-1501.
[5] 郑格琳, 张平, 郭洁, 等. 补阳还五汤抑制脊髓损伤区内硫酸软骨素蛋白聚糖表达的实验研究[J]. 中华中医药杂志, 2009, 24(5): 678-680.
[6] DENG L X, DENG P, RUAN Y, et al. A novel growth-promoting pathway formed by GDNF-overexpressing Schwann cells promotes propriospinal axonal regeneration, synapse formation, and partial recovery of function after spinal cord injury[J]. J Neurosci, 2013, 33(13): 5655-5667.
[7] HOLLY L T, BLASKIEWICZ D, WU A, et al. Dietary therapy to promote europrotection in chronic spinal cord injury [J]. J Neurosurg Spine, 2012, 17(2): 134-140.
[8] SENGUL G, COBAN M K, CAKIR M, et al. Neuroprotective effect of acute interferon-beta 1B treatment after spinal cord injury[J]. Turk Neurosurg, 2013, 23(1): 45-49.
[9] 胥少汀, 葛宝丰, 徐印坎. 实用骨科学[M]. 3版. 北京: 人民军医出版社, 2006: 582-606.
[10] 朱文锋. 中医诊断学[M]. 北京: 中国中医药出版社, 2002: 165-169.
[11] 郑筱萸. 中药新药临床研究指导原则[M]. 北京: 中国医药科技出版社, 2002: 379-383. |
|
|
|